Cogent Biosciences (COGT) Change in Acquisitions & Divestments (2017 - 2026)

Cogent Biosciences' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $97.8 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 39.91% year-over-year to $97.8 million; the TTM figure through Mar 2026 stood at $317.1 million (up 9.25% YoY), while the FY2025 annual figure was $289.2 million, down 1.78% from the prior year.
• Change in Acquisitions & Divestments was $97.8 million for Q1 2026 at Cogent Biosciences, up from $73.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $120.0 million in Q1 2023 to a low of $22.1 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $71.9 million across 4 years, with a median of $73.3 million in 2025.
• Biggest YoY gain for Change in Acquisitions & Divestments was 262.41% in 2024; the steepest drop was 38.23% in 2024.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $61.7 million in 2023, then climbed by 20.66% to $74.5 million in 2024, then dropped by 1.62% to $73.3 million in 2025, then soared by 33.53% to $97.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $97.8 million (Q1 2026), $73.3 million (Q4 2025), and $69.1 million (Q3 2025), per Business Quant data.